MX18786A - Complejos macrociclicos de acido aminofonico, su preparacion, formulaciones y empleo. - Google Patents

Complejos macrociclicos de acido aminofonico, su preparacion, formulaciones y empleo.

Info

Publication number
MX18786A
MX18786A MX1878689A MX1878689A MX18786A MX 18786 A MX18786 A MX 18786A MX 1878689 A MX1878689 A MX 1878689A MX 1878689 A MX1878689 A MX 1878689A MX 18786 A MX18786 A MX 18786A
Authority
MX
Mexico
Prior art keywords
aminophonic
employment
formulations
preparation
acid
Prior art date
Application number
MX1878689A
Other languages
English (en)
Inventor
Jaime Simon
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of MX18786A publication Critical patent/MX18786A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/06—Chelate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX1878689A 1988-12-19 1989-12-19 Complejos macrociclicos de acido aminofonico, su preparacion, formulaciones y empleo. MX18786A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/284,876 US5059412A (en) 1984-06-04 1988-12-19 Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors

Publications (1)

Publication Number Publication Date
MX18786A true MX18786A (es) 1993-12-01

Family

ID=23091854

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1878689A MX18786A (es) 1988-12-19 1989-12-19 Complejos macrociclicos de acido aminofonico, su preparacion, formulaciones y empleo.

Country Status (26)

Country Link
US (1) US5059412A (es)
EP (2) EP0408701B1 (es)
JP (1) JP2515929B2 (es)
KR (1) KR0178966B1 (es)
CN (1) CN1025983C (es)
AR (1) AR248140A1 (es)
AT (1) ATE112689T1 (es)
AU (3) AU639899B2 (es)
BR (1) BR8907255A (es)
CA (1) CA2005880C (es)
CY (1) CY1902A (es)
DE (1) DE68918852T2 (es)
DK (1) DK175479B1 (es)
ES (1) ES2061010T3 (es)
FI (1) FI101857B1 (es)
HK (1) HK146795A (es)
HU (1) HU207454B (es)
IE (2) IE66391B1 (es)
IL (1) IL92784A (es)
MX (1) MX18786A (es)
NO (1) NO180434C (es)
NZ (1) NZ231818A (es)
PT (1) PT92619B (es)
SA (1) SA91120234B1 (es)
WO (1) WO1990006776A1 (es)
ZA (1) ZA899734B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5645818A (en) * 1989-03-24 1997-07-08 Guerbet S.A. Diagnostic compositions comprising a complex formed by a nitrogenous macrocyclic ligand with metal ions
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
WO1991016075A1 (en) * 1990-04-20 1991-10-31 Australian Nuclear Science & Technology Organisation Bone marrow treatments
MC2260A1 (fr) * 1990-06-18 1993-04-26 Dow Chemical Co Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation
BR9102490A (pt) * 1990-06-18 1992-01-21 Dow Chemical Co Metodo para uso diagnostico na formacao de imagens e composicao
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
US5739294A (en) * 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
EP0841951A2 (en) * 1995-06-26 1998-05-20 Concat Ltd. Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
US6005083A (en) * 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
EP1191948A2 (en) * 1999-06-11 2002-04-03 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
WO2002062398A2 (en) 2001-01-08 2002-08-15 Neorx Corporation Radioactively labelled conjugates of phosphonates
US20020094316A1 (en) * 2001-01-09 2002-07-18 Shuang Liu Polypodal chelants for metallopharmaceuticals
EP1458416A1 (en) 2001-12-13 2004-09-22 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
US20030228256A1 (en) * 2002-06-11 2003-12-11 Inverardi Luca A. Methods of achieving transplantation tolerance through radioablation of hemolymphopoietic cell populations
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
WO2011149844A1 (en) * 2010-05-24 2011-12-01 Iso Therapeutics Group Llc Delivery of high dose therapeutic radioisotopes to bone
PL3054996T3 (pl) 2013-10-07 2023-09-18 Igl Pharma, Inc. Sposób wytwarzania wysoce czystych środków do leczenia kości
EP3302496B1 (en) * 2015-05-25 2021-01-06 IGL Pharma, Inc. Dotmp kit formulations for radioisotopes
US11369700B2 (en) 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
IL265536B (en) 2016-09-27 2022-07-01 Bayer Pharma AG A method for the production of a crystalline form of the a modification of calcobuterol
JP2020506239A (ja) 2017-02-08 2020-02-27 アイジーエル ファーマ，インコーポレイティド 治療用骨剤の使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965254A (en) * 1973-05-23 1976-06-22 The Procter & Gamble Company Compositions for the treatment of calcific tumors
US4017595A (en) * 1975-08-28 1977-04-12 Research Corporation Bone-seeking indium-113m or indium-111 organic phosphonate complexes
CA1078731A (en) * 1976-12-16 1980-06-03 Charles E. Frosst And Co. Skeletal imaging kit utilizing triethylene tetramine hexa (methylene phosphonic acid)
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
SU1098937A1 (ru) * 1983-03-25 1984-06-23 Ордена Ленина институт элементоорганических соединений им.А.Н.Несмеянова 1,4,7,10-Тетра/диоксифосфорилметил/-1,4,7,10-тетраазациклододекан в качестве комплексона дл св зывани катионов меди /п/,кобальта /п/,кадми /п/,свинца /п/ и лантана /ш/
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
DE164843T1 (de) * 1984-06-04 1989-12-07 The Dow Chemical Co., Midland, Mich. Organische aminphosphonsaeurekomplexe fuer die behandlung von verkalkenden tumoren.
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
FR2614020B1 (fr) * 1987-04-14 1989-07-28 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
US4853209A (en) * 1987-05-18 1989-08-01 The Dow Chemical Company Bone marrow suppressing agents
US4882142A (en) * 1988-12-19 1989-11-21 The Dow Chemical Company Bone marrow suppressing agents
US4976950A (en) * 1988-12-19 1990-12-11 The Dow Chemical Company Bone marrow suppressing agents

Also Published As

Publication number Publication date
IE940833L (en) 1990-06-19
AU4700989A (en) 1990-06-21
AU639899B2 (en) 1993-08-12
HU901163D0 (en) 1991-03-28
IE894063L (en) 1990-06-19
DK195990A (da) 1990-08-16
HUT54897A (en) 1991-04-29
DE68918852T2 (de) 1995-05-11
SA91120234B1 (ar) 2004-09-04
BR8907255A (pt) 1991-03-12
KR0178966B1 (ko) 1999-03-20
EP0408701A1 (en) 1991-01-23
FI101857B (fi) 1998-09-15
HK146795A (en) 1995-09-22
NO180434C (no) 1997-04-23
AR248140A1 (es) 1995-06-30
DK175479B1 (da) 2004-11-08
IL92784A (en) 1994-08-26
AU5068593A (en) 1994-02-24
WO1990006776A1 (en) 1990-06-28
AU4828290A (en) 1990-07-10
CA2005880A1 (en) 1990-06-19
KR910700073A (ko) 1991-03-13
EP0375376A3 (en) 1991-06-12
NZ231818A (en) 1992-05-26
PT92619B (pt) 1995-09-12
NO903632D0 (no) 1990-08-17
ATE112689T1 (de) 1994-10-15
ES2061010T3 (es) 1994-12-01
CN1025983C (zh) 1994-09-28
CY1902A (en) 1989-12-15
EP0408701B1 (en) 1994-10-12
EP0375376A2 (en) 1990-06-27
IL92784A0 (en) 1990-09-17
US5059412A (en) 1991-10-22
ZA899734B (en) 1991-08-28
EP0408701A4 (en) 1991-07-31
JPH03502936A (ja) 1991-07-04
PT92619A (pt) 1990-06-29
CA2005880C (en) 1999-01-05
JP2515929B2 (ja) 1996-07-10
DK195990D0 (da) 1990-08-16
HU207454B (en) 1993-04-28
NO180434B (no) 1997-01-13
FI101857B1 (fi) 1998-09-15
NO903632L (no) 1990-10-17
CN1046739A (zh) 1990-11-07
AU657641B2 (en) 1995-03-16
IE66391B1 (en) 1995-12-27
FI904084A0 (fi) 1990-08-17
DE68918852D1 (de) 1994-11-17

Similar Documents

Publication Publication Date Title
MX18786A (es) Complejos macrociclicos de acido aminofonico, su preparacion, formulaciones y empleo.
NO875045L (no) Fremgangsmaate for fremstilling av topiske preparater for behandling av akne.
NO880812D0 (no) Fremstilling av zeolitt l.
IT8847956A0 (it) Benzo-b-pirani e piranopiridone, loro preparazione e loro impiego come medicamenti
NO861956L (no) Fremgangsmaate for fremstilling av askorbinsyrederivater.
AU587622B2 (en) Isoxazole and furan derivatives, their preparation and use as antiviral agents
NL194749B (nl) Stabiel calciumhoudend farmaceutisch preparaat.
ES2022889B3 (es) Derivados de tiolactama-n-acido acetico, su produccion y uso.
IL84925A0 (en) 1h-imidazole-5-carboxylic acid derivatives,their preparation and their use as herbicides
NZ221513A (en) Triazolylmethyl- and imidazolylmethyl- 2,5-dihydrofuran derivatives and fungicidal compositions
MX9203090A (es) Derivados de finilisopropilamina y su preparacion.
IL84801A (en) 26-alkenoxy milbemycin derivatives,processes for their preparation and pesticidal compositions containing the same
IL81674A0 (en) 1h-imidazole-5-carboxylic acid derivatives,their preparation and their use as herbicides
IT8620297A0 (it) Composti stabilizzanti eprocedimento per la loro preparazione.
IT8548385A0 (it) Composti maftalenici,loro preparazi one e loro impiego come medicamenti
AU7143887A (en) Benzimidazolesulfonamides and imidazopyridine-sulfonamides, their preparation and their application as drugs
IL73610A0 (en) Macrocyclic lactones,their preparation and their use as pesticides
IT8447964A1 (it) Complessi d'inclusione, loro preparazione e loro impiego come insetticidi.
NO893143D0 (no) Fremstilling av klordioksyd.
NO893165L (no) Fremstilling av klorsyre.
IL84978A0 (en) 1-methyl-1h-imidazole-5-carboxylic acid derivatives,their preparation and their use as herbicides
NO873365D0 (no) Pulvermetallurgisk fremstilling.
FI874400A0 (fi) Foerfarande foer framstaellning av imidazo-4,5-b pyridin-2-on-derivat.
DE3689036D1 (de) Lankacidinderivate und ihre Herstellung.
NO892470L (no) Fremstilling av laktolderivater.